Publikation

Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

Wissenschaftlicher Artikel/Review - 18.03.2013

Bereiche
PubMed
DOI

Zitation
Broglie Däppen M, Soltermann A, Rohrbach D, Haile S, Pawlita M, Studer G, Huber G, Moch H, Stöckli S. Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head & neck 2013; 35:1698-706.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Head & neck 2013; 35
Veröffentlichungsdatum
18.03.2013
eISSN (Online)
1097-0347
Seiten
1698-706
Kurzbeschreibung/Zielsetzung

BACKGROUND
Analysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT).

METHODS
One hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%).

RESULTS
Survival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups.

CONCLUSIONS
A risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. © 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013.